Back to results
US 11,635,433 B2Granted
Method for labeling intracellular and extracellular targets of leukocytes
AssigneeBeckman Coulter, Inc.
InventorsFabrice Malergue, Andreas Van Agthoven
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for labeling intracellular and extracellular targets of leukocytes, as well as to kits for performing said methods.
Claims15
A method for labeling a marker of leukocytes, comprising the steps of:
- (a) forming a first combination including:
- (i) a cellular composition comprising leukocytes, and
- (ii) a cross-linking agent that is formaldehyde, wherein the concentration of said cross-linking agent in said first combination is 0.5% to 2% (v/v);
- (b) forming a second combination including:
- (i) said first combination,
- (ii) a solution comprising a permeabilizing agent that permeabilizes said leukocytes and a neutralizing agent comprising a mixture of sodium chloride and (NaCl) and ammonium chloride (NH4Cl) and optionally glycine, tris(hydroxymethyl)aminomethane (Tris), ethanolamine, or a mixture thereof, in a concentration of 1 to 100 mM in said solution, wherein said neutralizing agent neutralizes the cross-linking activity of said cross-linking agent and a pH of said solution is in a range of 6.0 and 6.6;
- and
- (iii) a binding agent that binds a marker of said leukocyte, wherein the binding agent comprises a detectable agent,
- wherein no centrifugation is performed between step (a) and step (b) and the permeabilizing agent is added in an amount sufficient so as to permeabilize said leukocytes, and so as to lyse said red blood cells to effect the lysis of substantially all red blood cells contained in the cellular composition, while the majority of leukocytes contained in the cellular composition are not lysed.
6 more elements
A method for labeling a marker of leukocytes, comprising the steps of:
- (a) forming a first combination including:
- (i) a cellular composition comprising leukocytes, and
- (ii) a cross-linking agent selected from the group consisting of formaldehyde, paraformaldehyde, and glutaraldehyde, wherein the concentration of said cross-linking agent in said first combination is 0.5% to 2% (v/v);
- (b) forming a second combination including:
- (i) said first combination,
- (ii) a permeabilizing agent that permeabilizes said leukocytes,
- (iii) a neutralizing agent comprising a mixture of ammonium chloride (NH4Cl) and sodium chloride and optionally, glycine, tris(hydroxymethyl)aminomethane (Tris), and ethanolamine, wherein said neutralizing agent has a concentration of 1 to 100 mM in said mixture and neutralizes the cross-linking activity of said cross-linking agent;
- and
- (iv) a binding agent that binds a marker of said leukocytes, wherein the binding agent comprises a detectable agent, wherein said binding agent is added after step (a) and no centrifugation is performed between step (a) and step (b), wherein a pH of the neutralizing agent mixture is in a range of 6.0 and 6.6.
6 more elements
A method for preparing leukocytes for staining, comprising the steps of:
- (a) forming a first combination including:
- (i) a cellular composition comprising leukocytes, and
- (ii) a cross-linking agent selected from the group consisting of formaldehyde, paraformaldehyde, and glutaraldehyde, wherein the concentration of said cross-linking agent in said first combination is 0.5% to 2% (v/v);
- (b) forming a second combination including:
- (i) said first combination, and
- (ii) a solution comprising a permeabilizing agent containing a C12-type alkane residue that permeabilizes said leukocytes and a neutralizing agent comprising a mixture of sodium chloride and (NaCl) and ammonium chloride (NH4Cl) and optionally glycine, tris(hydroxymethyl)aminomethane (Tris), ethanolamine, or a mixture thereof, wherein said neutralizing agent has a concentration of 1 to 100 mM in said mixture and neutralizes the cross-linking activity of said cross-linking agent and a pH of said solution is in a range of 6.0 and 6.6,
- wherein no centrifugation is performed between step (a) and step (b) and the permeabilizing agent is added in an amount sufficient to permeabilize said leukocytes, and so as to lyse said red blood cells, wherein said permeabilizing agent is in an amount adapted to effect the lysis of substantially all red blood cells contained in the cellular composition, while the majority of leukocytes contained in the cellular composition are not lysed.
4 more elements
Dependencies are inferred from the claim text.